CTI BIOPHARMA CORP (CTIC)

US12648L6011 - Common Stock

9.09  0 (0%)

After market: 9.09 0 (0%)

Unregistered users can only see 4 years or quarters

Examples of complete financials are available for MSFT and AAPL.

Please register or login for additional data.

TTM
(2023-3-31)
2022
(2022-12-31)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
CASH FLOWS FROM OPERATING ACTIVITIES
Net Income
-69.24M-92.99M-97.91M-52.45M-40.02M
Depreciation Amortization
2.15M1.95M526.00K530.00K550.00K
Change In Working Capital
-35.94M-7.92M7.86M-2.42M7.76M
Interest Paid
6.74M6.13M1.95M550.00K1.04M
Taxes Paid
N/AN/AN/AN/AN/A
Other non cash items
20.71M17.77M4.63M12.14M3.89M
OPERATING CASH FLOW
-82.31M-81.19M-84.89M-42.21M-27.82M
 
CASH FLOWS FROM INVESTING ACTIVITIES
Capital Expenditure
N/AN/A0.00-20.00K0.00
Other Investing Activity
-58.60M-73.85M12.00M-9.60M28.13M
INVESTING CASH FLOW
-58.60M-73.85M12.00M-9.62M28.13M
 
CASH FLOWS FROM FINANCING ACTIVITIES
Debt Issued/Reduced
6.50M60.00M-6.33M-5.33M-5.33M
Stock Issued/Repurchased
9.44M6.37M56.41M66.41M0.00
Other Financing Activity
52.28M53.66M47.86M0.00-280.00K
FINANCING CASH FLOW
68.22M120.02M97.94M61.07M-5.61M
 
Exchange Rate Effect
N/AN/AN/A0.000.00
CHANGE IN CASH
-72.69M-35.03M25.05M9.24M-5.30M
 
FREE CASH FLOW
Operating Cash Flow
-82.31M-81.19M-84.89M-42.21M-27.82M
Capital Expenditure
N/AN/A0.00-20.00K0.00
FREE CASH FLOW
-82.31M-81.19M-84.89M-42.23M-27.82M

All data in USD

Charts